Literature DB >> 26119485

Mutual induction of transcription factor PPARγ and microRNAs miR-145 and miR-329.

Ashutosh Dharap1, Courtney Pokrzywa1, Shruthi Murali1, Balarama Kaimal1, Raghu Vemuganti1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that are known to control mRNA translation. Most miRNAs are transcribed from specific genes with well-defined promoters located throughout the genome. The mechanisms that control miRNA expression under normal and pathological conditions are not yet understood clearly. Peroxisome proliferator-activated receptor (PPAR) γ is a ligand-activated transcription factor that is extensively distributed in the CNS. PPARγ activation induces neuroprotection by modulating genes that contain peroxisome proliferator response elements (PPREs) in their promoters. We presently evaluated if PPARγ modulates miRNA expression. When adult rats were treated with PPARγ agonist rosiglitazone, expression of 28 miRNAs altered significantly (12 up- and 16 down-regulated; 3-119 fold) in the cerebral cortex compared to vehicle-treated controls. In silico analysis showed 1-5 PPREs in the putative promoter regions (within 1 Kb upstream of the transcription start site) of these miRNA genes. Cotransfection with a PPARγ constitutively expressing vector significantly induced the miR-145 and miR-329 promoter vectors (each have four PPREs), which was curtailed by point mutations of PPREs in their promoters. Interestingly, the PPARγ promoter has binding sites for both these miRNAs and transfection with miR-329 mimic and miR-145 mimic induced the PPARγ expression. Thus, these studies show a cyclical induction of miRNAs and PPARγ, indicating that the pleiotropic beneficial effects of PPARγ agonists might be modulated in part by miRNAs and their down-stream mRNAs. We proposed that promoters of many microRNAs contain the binding sites for the transcription factor PPARγ. Activation of PPARγ modulates the expression of these microRNAs. Two such PPARγ-responsive microRNAs (miR-145 and miR-329) bind to PPARγ promoter to induce its expression. This indicates the presence of a feedback loop by which transcription factors and microRNAs can modulate each other.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  gene induction; miRNA; non-coding RNA; peroxisome proliferator-activated receptor; promoters; transcription factor

Mesh:

Substances:

Year:  2015        PMID: 26119485      PMCID: PMC4896071          DOI: 10.1111/jnc.13220

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

Review 2.  Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders.

Authors:  Paul D Drew; Jihong Xu; Paul D Storer; Janet A Chavis; Michael K Racke
Journal:  Neurochem Int       Date:  2006-06-05       Impact factor: 3.921

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 4.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

5.  Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways.

Authors:  Ashutosh Dharap; Raghu Vemuganti
Journal:  J Neurochem       Date:  2010-04-06       Impact factor: 5.372

Review 6.  Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.

Authors:  Jia Liu; Lu-ning Wang; Jian-ping Jia
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

7.  PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.

Authors:  Jae-Hyuk Yi; Seung-Won Park; Nathaniel Brooks; Bradley T Lang; Raghu Vemuganti
Journal:  Brain Res       Date:  2008-10-09       Impact factor: 3.252

8.  MicroRNA-373 induces expression of genes with complementary promoter sequences.

Authors:  Robert F Place; Long-Cheng Li; Deepa Pookot; Emily J Noonan; Rajvir Dahiya
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-28       Impact factor: 11.205

Review 9.  PPAR-γ: therapeutic prospects in Parkinson's disease.

Authors:  Anna R Carta
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  15 in total

1.  Circular RNA Expression Profiles Alter Significantly in Mouse Brain After Transient Focal Ischemia.

Authors:  Suresh L Mehta; Gopal Pandi; Raghu Vemuganti
Journal:  Stroke       Date:  2017-07-12       Impact factor: 7.914

Review 2.  Peroxisome Plasticity at the Virus-Host Interface.

Authors:  Katelyn C Cook; Jorge A Moreno; Pierre M Jean Beltran; Ileana M Cristea
Journal:  Trends Microbiol       Date:  2019-07-19       Impact factor: 17.079

Review 3.  Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song; Jingrong Lin
Journal:  Mol Cell Biochem       Date:  2022-03-29       Impact factor: 3.396

4.  Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.

Authors:  Hua-Yu Zhu; Wen-Dong Bai; Hong-Tao Wang; Song-Tao Xie; Ke Tao; Lin-Lin Su; Jia-Qi Liu; Xue-Kang Yang; Jun Li; Yun-Chuan Wang; Ting He; Jun-Tao Han; Da-Hai Hu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

Review 5.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

6.  MicroRNA-26a/b and their host genes synergistically regulate triacylglycerol synthesis by targeting the INSIG1 gene.

Authors:  Hui Wang; Jun Luo; Tianying Zhang; Huibin Tian; Yue Ma; Huifen Xu; Dawei Yao; Juan J Loor
Journal:  RNA Biol       Date:  2016-03-22       Impact factor: 4.652

Review 7.  Noncoding RNA crosstalk in brain health and diseases.

Authors:  Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2021-07-16       Impact factor: 4.297

Review 8.  MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.

Authors:  Dorothea Portius; Cyril Sobolewski; Michelangelo Foti
Journal:  PPAR Res       Date:  2017-01-12       Impact factor: 4.964

9.  Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats.

Authors:  Marcin Gamdzyk; Desislava Met Doycheva; Jay Malaguit; Budbazar Enkhjargal; Jiping Tang; John H Zhang
Journal:  Neuropharmacology       Date:  2018-08-04       Impact factor: 5.273

10.  Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced skin inflammation.

Authors:  Gwendoline Degueurce; Ilenia D'Errico; Christine Pich; Mark Ibberson; Frédéric Schütz; Alexandra Montagner; Marie Sgandurra; Lionel Mury; Paris Jafari; Akash Boda; Julien Meunier; Roger Rezzonico; Nicolò Costantino Brembilla; Daniel Hohl; Antonios Kolios; Günther Hofbauer; Ioannis Xenarios; Liliane Michalik
Journal:  EMBO Mol Med       Date:  2016-08-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.